The center will apply genomic approaches to develop more effective therapies for rheumatoid arthritis and lupus. The center will have an estimated 20 scientists, led by Lionel B. Ivashkiv, MD, director, and Shiaoching Gong, PhD, co-director.
More Articles on Genomics:
Roswell Park Cancer Institute Now a Member of New York Genome Center
Boston Children’s Hospital Takes Stake in For-Profit Genomics Company
Brigham and Women’s, Dana-Farber Launch Research Project for Cancer Genomics
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
